天津大学教师个人主页系统贺小宁 Cost-effectiveness analysis of trilaciclib for reducing the incidence of chemotherapy-induced myelosuppression among patients with extensive-stage small cell lung cancer in China Home

中文

Brief Introduction
Education Background
Research Interests
Courses
Professional Membership
Positions & Employments
Academic achievements
Honors & Awards
Team
Album

Xiaoning He

School

School of Pharmaceutical Science and Technology, Medical College

Professional Title

Associate professor

Discipline

Health and Pharmacy Administration

Other Contact Information

Selected Papers

Current position: Home > Academic Achievements > Selected Papers

Cost-effectiveness analysis of trilaciclib for reducing the incidence of chemotherapy-induced myelosuppression among patients with extensive-stage small cell lung cancer in China

Hits:

Journal:Expert Rev Pharmacoecon Outcomes Res

All the Authors:Fang N, Xia X, He X*

Translation or Not:no

CN No.:null

Pre One:Matching-adjusted indirect comparison and cost-effectiveness of mitoxantrone hydrochloride liposome versus Chidamide in relapsed or refractory peripheral T-cell lymphoma in China

Next One:Enhancing the Interpretation of Continuous Outcomes and Subgroup Analyses in Systematic Reviews